Globus Medical (GMED): Director filed to sell ~$3.13M
TOBIN JAMES R, Director at Globus Medical, filed to sell ~$3.13M of Globus Medical shares.
- ~$3.13M
- planned to sell · 42K shares, around Nov 10, 2026
- Planned for
- Nov 10, 2026
- Notice filed
- Nov 10, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Sep 3, 2026CongressDisclosed purchase of GMED — reported range $1,001 - $15,000
- Sep 15, 2026Insider · Their largest sale since 2019Director sold ~$2.24M of GMED shares in the open market
- Oct 23, 2026FDAFDA device clearance: ANTHEM Fracture System
- Oct 27, 20265% stakeBlackRock, Inc. reported a passive stake (13G) of 8.0%
- Oct 30, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 4.4%
- Nov 4, 2026InsiderDirector sold ~$425K of GMED shares in the open market
- Nov 5, 2026Company filing · Form 8-K · Results, Other newsReported its results, and reported other company news
- Nov 10, 2026Insider · 1 personInsiders: 2 sales (~$3.1M)
How to read SEC Form 144
Form 144 is a notice that a company insider plans to sell shares. It is filed when the sell order is placed, so it announces a planned sale and does not prove that the sale took place.
Full guide: What is an SEC Form 144?
What else is on file for Globus Medical
For Globus Medical, OQRO holds 6 insider filings (SEC Form 4 or Form 144), 2 Congress trade reports and 1 fund holdings report (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its GMED page.
How this filing works
Explore the data
Common questions
Which Globus Medical (GMED) insider traded, and how much?
TOBIN JAMES R, Director at Globus Medical, filed to sell ~$3.13M of Globus Medical shares. 42K shares, Form 144 notice of a planned sale.
When did it happen, and when was it made public?
Planned for: Nov 10, 2026. Notice filed: Nov 10, 2026.
Is the dollar amount exact?
It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.
Where does this information come from?
From the SEC Form 144, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Globus Medical recently?
For Globus Medical, OQRO holds 6 insider filings (SEC Form 4 or Form 144), 2 Congress trade reports and 1 fund holdings report (13F) dated in the last 90 days. They are listed on the GMED page.
Does this mean GMED stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Globus Medical
- SEC Form 13F-HRNov 16, 2026
- SEC Form 4Nov 12, 2026
- SEC Form 4Nov 12, 2026
- SEC Form 4Nov 5, 2026
- SEC Form 144Nov 4, 2026
- House Clerk periodic transaction reportOct 12, 2026
Everything OQRO holds on this company is on its GMED page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
